CRD-102 / Cardiora - LARVOL DELTA

Extended Release Oral Milrinone, CRD-102, for Advanced Heart Failure. (PubMed, Am J Cardiol) - "In conclusion, the present study demonstrates evidence of beneficial actions of extended release milrinone in advanced HF. Longer-term randomized clinical trial data are required."

Journal

CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices (clinicaltrials.gov) - P1/2; N=6; Completed; Sponsor: Cardiora Pty. Ltd.; Recruiting ➔ Completed; N=10 ➔ 6; Trial primary completion date: Apr 2019 ➔ Oct 2018

Clinical • Enrollment change • Trial completion • Trial primary completion date